Scintegra Therapeutics Trademark Details

This mark is dead with a status of Abandoned - No Statement of Use Filed. The last case file activity for this mark occured 12 years ago on Monday, July 18, 2011, according to the United State Patent & Trademark Office
Word Mark Scintegra Therapeutics
Status Dead 606 — Abandoned - No Statement of Use Filed

Current Owner

Nps Pharmaceuticals, Inc. of Bedminster, NJ

View all trademarks for Nps Pharmaceuticals, Inc.
Other Trademarks for Nps Pharmaceuticals, Inc.
Serial Number 77211632
Status Date Monday, July 18, 2011
Filing Date Monday, July 18, 2011
Attorney Michael E. Mangelson

Correspondent

MICHAEL E. MANGELSON
STOEL RIVES LLP
201 S MAIN ST STE 1100
SALT LAKE CITY UT 84111-4904

Case File Statements

Disclaimer with Predetermined Text "Therapeutics"
Goods & Services Pharmaceutical preparations for the treatment or prevention of gastrointestinal disorders, infectious diseases, cancer, immune system disorders, diseases involving varying levels of calcium in cells and outside cells, neurological or other central nervous system disorders, endocrine disorders, and bone metabolism disorders; pharmaceutical preparations for use in effecting analgesia and in pain management
Translation of Words in Mark "Scintegra" has no meaning in a foreign language.

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Monday, June 25, 2007
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.